164 related articles for article (PubMed ID: 16060718)
1. Causes of syncope in patients with Alzheimer's disease treated with donepezil.
Bordier P; Lanusse S; Garrigue S; Reynard C; Robert F; Gencel L; Lafitte A
Drugs Aging; 2005; 22(8):687-94. PubMed ID: 16060718
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular effects and risk of syncope related to donepezil in patients with Alzheimer's disease.
Bordier P; Garrigue S; Lanusse S; Margaine J; Robert F; Gencel L; Lafitte A
CNS Drugs; 2006; 20(5):411-7. PubMed ID: 16696580
[TBL] [Abstract][Full Text] [Related]
3. Significance of syncope in patients with Alzheimer's disease treated with cholinesterase inhibitors.
Bordier P; Garrigue S; Barold SS; Bressolles N; Lanusse S; Clémenty J
Europace; 2003 Oct; 5(4):429-31. PubMed ID: 14753643
[TBL] [Abstract][Full Text] [Related]
4. Complete atrioventricular block and ventricular tachyarrhythmia associated with donepezil.
Suleyman T; Tevfik P; Abdulkadir G; Ozlem S
Emerg Med J; 2006 Aug; 23(8):641-2. PubMed ID: 16858101
[TBL] [Abstract][Full Text] [Related]
5. Donepezil and cardiac syncope: case report.
Jane Newby V; Anne Kenny R; McKeith IG
Int J Geriatr Psychiatry; 2004 Nov; 19(11):1110-2. PubMed ID: 15497193
[No Abstract] [Full Text] [Related]
6. Donepezil: syncope. Various cardiac disorders.
Prescrire Int; 2008 Jun; 17(95):113. PubMed ID: 18630357
[No Abstract] [Full Text] [Related]
7. [Symptomatic sinus bradycardia associated with donepezil].
Calvo-Romero JM; Ramos-Salado JL
Rev Neurol; 1999 Jun 1-15; 28(11):1070-2. PubMed ID: 10390778
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
[TBL] [Abstract][Full Text] [Related]
9. Donepezil-induced cervical dystonia in Alzheimer's disease: a case report and literature review of dystonia due to cholinesterase inhibitors.
Ikeda K; Yanagihashi M; Sawada M; Hanashiro S; Kawabe K; Iwasaki Y
Intern Med; 2014; 53(9):1007-10. PubMed ID: 24785894
[TBL] [Abstract][Full Text] [Related]
10. Effects of donepezil on liver and kidney functions for the treatment of Alzheimer's disease.
Erbayraktar Z; Evlice A; Yener G; Ulusu NN
J Integr Neurosci; 2017; 16(3):335-346. PubMed ID: 28891516
[TBL] [Abstract][Full Text] [Related]
11. Donepezil-related toxic hepatitis.
Dierckx RI; Vandewoude MF
Acta Clin Belg; 2008; 63(5):339-42. PubMed ID: 19186568
[TBL] [Abstract][Full Text] [Related]
12. Acetylcholinesterase inhibitors and sleep architecture in patients with Alzheimer's disease.
Cooke JR; Loredo JS; Liu L; Marler M; Corey-Bloom J; Fiorentino L; Harrison T; Ancoli-Israel S
Drugs Aging; 2006; 23(6):503-11. PubMed ID: 16872233
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial.
Feldman H; Gauthier S; Hecker J; Vellas B; Xu Y; Ieni JR; Schwam EM;
Int J Geriatr Psychiatry; 2005 Jun; 20(6):559-69. PubMed ID: 15920715
[TBL] [Abstract][Full Text] [Related]
14. Upper gastrointestinal bleed associated with cholinesterase inhibitor use.
Kok KS; Loke Y; Southgate J
BMJ Case Rep; 2015 Sep; 2015():. PubMed ID: 26420698
[TBL] [Abstract][Full Text] [Related]
15. Use of clarithromycin and adverse cardiovascular events among older patients receiving donepezil: a population-based, nested case-control study.
Hutson JR; Fischer HD; Wang X; Gruneir A; Daneman N; Gill SS; Rochon PA; Anderson GM
Drugs Aging; 2012 Mar; 29(3):205-211. PubMed ID: 22372724
[TBL] [Abstract][Full Text] [Related]
16. Torsades de Pointes with QT prolongation related to donepezil use.
Takaya T; Okamoto M; Yodoi K; Hata K; Kijima Y; Nakajima H; Nishikawa Y; Kita T; Ito M; Seo T; Kawashima S
J Cardiol; 2009 Dec; 54(3):507-11. PubMed ID: 19944332
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of open-label donepezil treatment in patients with Alzheimer's disease discontinuing memantine monotherapy.
Sakka P; Tsolaki M; Hort J; Hager K; Soininen H; López Pousa S; Li C; Schwam E
Curr Med Res Opin; 2007 Dec; 23(12):3153-65. PubMed ID: 17988434
[TBL] [Abstract][Full Text] [Related]
18. Cervical dystonia in an Alzheimer's disease patient treated with donepezil.
Yagi Y; Watanabe Y; Yokote H; Amino T; Kamata T
Acta Neurol Belg; 2013 Sep; 113(3):363-4. PubMed ID: 23055114
[No Abstract] [Full Text] [Related]
19. Donepezil-induced adverse side effects of cardiac rhythm: 2 cases report of atrioventricular block and Torsade de Pointes.
Tanaka A; Koga S; Hiramatsu Y
Intern Med; 2009; 48(14):1219-23. PubMed ID: 19602789
[TBL] [Abstract][Full Text] [Related]
20. Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in Japan.
Homma A; Imai Y; Tago H; Asada T; Shigeta M; Iwamoto T; Takita M; Arimoto I; Koma H; Takase T; Ohbayashi T
Dement Geriatr Cogn Disord; 2009; 27(3):232-9. PubMed ID: 19246907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
